GGrantIndex
← Leaderboards

Yi Shi

Icahn School Of Medicine At Mount Sinai

$3,269,966
Attributed
$5,237,446
Total exposure
3
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.4M · FY202025
$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,237,446 · 3

By mechanism

R01$2,505,945 · 1
R35$2,137,800 · 1
R21$593,701 · 1

Top collaborators

Most similar at Icahn School Of Medicine At Mount Sinai

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Affinity

Research focus

AffinityNanobodiesTechnologyProteomicsAntibodiesProductionStructureCostBiomedical EngineeringPharmaceutical PreparationsBindingCohortAntigensImmune ResponseMolecular ConformationSpecificityThermostabilitySolubilityInsightCommunitiesInterestReportingResolutionImmunoglobulin G

Grant awards (13)

Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$535,044
R01 · FY2025 · AI · contact PI
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$587,096
R01 · FY2024 · AI · contact PI
Development of the next generation antibody technologies and their applications$422,500
R35 · FY2024 · GM · contact PI
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$614,795
R01 · FY2023 · AI · contact PI
Development of the next generation antibody technologies and their applications$422,500
R35 · FY2023 · GM · contact PI
Using nanobodies to increase the sensitivity and resolution of chromatin profiling through uliCUT&RUN$186,813
R21 · FY2023 · CA
A Shimadzu micro-scale HPLC system for analysis of nanobody repertoires$86,758
R35 · FY2023 · GM · contact PI
Development of multivalent, ultrapotent nanobody cocktails for SARS-CoV-2 neutralization$769,010
R01 · FY2022 · AI · contact PI
Development of the next generation antibody technologies and their applications$422,500
R35 · FY2022 · GM · contact PI
Using nanobodies to increase the sensitivity and resolution of chromatin profiling through uliCUT&RUN$186,813
R21 · FY2022 · CA
Development of the next generation antibody technologies and their applications$392,292
R35 · FY2021 · GM · contact PI
Using nanobodies to increase the sensitivity and resolution of chromatin profiling through uliCUT&RUN$220,075
R21 · FY2021 · CA
Development of the next generation antibody technologies and their applications$391,250
R35 · FY2020 · GM · contact PI